Back to Journals » Drug Design, Development and Therapy » Volume 16

Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity

Total article views   HTML views PDF downloads Totals
6,300 Dovepress* 6,083+ 273 6,356
PubMed Central* 217 90 307
Totals 6,300 363 6,663
*Since 11 August 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 3 3

View citations on PubMed Central and Google Scholar